Validating your H&E Staining Systems
In this age of healthcare regulatory standards and compliance, every aspect in diagnostic patient care must be developed, documented, and validated ‘before’ they can be used in testing and diagnoses. Procedures which were once deemed as ‘routine’, as in the routine staining procedure (H&E) which constitutes 95-100% of most hospital initial testing review in histopathology; these procedures including protocol, stains, tissue specimens, and Q.A. monitoring and maintenance, all must go through stringent testing to show they produce reliable, reproducible results. This session will look at every aspect of your routine staining system from the stain dyes used (hematoxylin and eosin), various protocol trials with different staining intensities, the differences in instrumentation and how they perform, specimens being used to validate the stain, and technical review and sign-off by the pathologist.
Learning Objectives :
- Create a standard H&E multi-tissue control block
- Set up an internal quality assurance schedule
- Document and retain the validation procedure for regulatory inspection
Leica Biosystems webinars, training presentations and related materials provide general information regarding particular subjects and are not intended to be, and should not be construed as medical, regulatory or legal advice. The views and opinions expressed are the personal views and opinions of the speaker(s)/author(s) and do not necessarily represent or reflect the views or opinions of Leica Biosystems, its employees or agents.
For the use of any product, the product information guides, inserts and operation manuals of the various products and devices should be consulted. Leica Biosystems and the editors disclaim any liability arising directly or indirectly from the use of devices, techniques or procedures described in these materials.
Copyright © 2019 by Leica Biosystems Richmond Inc. All rights reserved.LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.